The Current Ratio as of December 2025 (TTM) for HBM Holdings Limited (HBMHF) is 6.05

According to HBM Holdings Limited’s latest financial reports and current stock price. The company's current Current Ratio is 6.05. This represents a change of 55.13% compared to the average of 3.90 of the last 4 quarters.

HBM Holdings Limited (HBMHF) Historical Current Ratio (quarterly & annually)

How has HBMHF Current Ratio performed in the past?

The mean historical Current Ratio of HBM Holdings Limited over the last ten years is 5.58. The current 6.05 Current Ratio has changed 10.75% with respect to the historical average. Over the past ten years (40 quarters), HBMHF's Current Ratio was at its highest in in the June 2021 quarter at 17.31. The Current Ratio was at its lowest in in the June 2018 quarter at 0.

HBM Holdings Limited (HBMHF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of HBM Holdings Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

HBM Holdings Limited (HBMHF) Average Current Ratio

How has HBMHF Current Ratio performed in the past?

The current Current Ratio of HBM Holdings Limited (HBMHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

HBM Holdings Limited (HBMHF) Current Ratio vs. Peers

How is HBMHF’s Current Ratio compared to its peers?

HBM Holdings Limited’s Current Ratio is less than Anebulo Pharmaceuticals, Inc. (17.34), less than Rezolute, Inc. (15.15), greater than HCW Biologics Inc. (0.06), less than Eliem Therapeutics, Inc. (14.08), less than Molecular Partners AG (9.35), greater than TRACON Pharmaceuticals, Inc. (0.89), greater than XOMA Royalty Corp. (3.91), greater than Sio Gene Therapies Inc. (5.52), greater than Vincerx Pharma, Inc. (1.79), greater than Virpax Pharmaceuticals, Inc. (0.63), greater than Acurx Pharmaceuticals, Inc. (2.39), less than MediciNova, Inc. (13.26), greater than NextCure, Inc. (3.71), less than Entera Bio Ltd. (10.83), less than Day One Biopharmaceuticals, Inc. (8.68), greater than Acumen Pharmaceuticals, Inc. (6.02), greater than X4 Pharmaceuticals, Inc. (3.19), greater than Inozyme Pharma, Inc. (2.19), less than VectivBio Holding AG (9.14), greater than Bio-Path Holdings, Inc. (0.09), greater than Endonovo Therapeutics, Inc. (0.00), greater than Cingulate Inc. (1.26), greater than Purple Biotech Ltd. (2.88), less than Soleno Therapeutics, Inc. (16.08),

Build a custom stock screener for HBM Holdings Limited (HBMHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HBM Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HBM Holdings Limited (HBMHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HBM Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.